Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Rhea-AI Summary

Haemonetics (NYSE: HAE) said President and CEO Chris Simon will speak in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 at 10:25 a.m. ET.

The event will be available via a live webcast on Haemonetics' Investor Relations site, with a replay posted 12 hours after the event and available for 90 days.

Haemonetics provides hospital and blood-collection technologies and end-to-end plasma collection solutions to improve healthcare outcomes.

Key Figures

Conference edition: 47th Annual Conference date: March 2, 2026 Conference time: 10:25 a.m. ET +2 more

5 metrics

Conference edition 47th Annual Raymond James Institutional Investors Conference

Conference date March 2, 2026 Scheduled fireside chat with investors

Conference time 10:25 a.m. ET Start time of Haemonetics fireside chat

Replay delay 12 hours Replay becomes accessible after live event

Replay availability 90 days Webcast replay on Investor Relations website

Market Reality Check

Price: $61.19 Vol: Volume 111,734 vs 20-day ...

low vol

$61.19 Last Close

Volume Volume 111,734 vs 20-day average 1,005,773 (relative volume 0.11) ahead of this conference news. low

Technical Price at $60.67, trading below 200-day MA of $66.27 and 30.52% under the 52-week high.

Peers on Argus

HAE was up 1.1% pre-news while close peers were mixed: ATEC -1.25%, INSP +1.05%,...

HAE was up 1.1% pre-news while close peers were mixed: ATEC -1.25%, INSP +1.05%, PRCT +0.53%, LIVN -0.1%, ITGR flat, suggesting stock-specific dynamics rather than a unified medical devices move.

Historical Context

5 past events · Latest: Feb 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 05	Earnings results post	Neutral	-1.4%	Q3 fiscal 2026 results and webcast made available to investors online.
Jan 09	Acquisition terms detail	Positive	-2.4%	Vivasure Medical acquisition terms up to €185M tied to milestones disclosed.
Jan 09	Acquisition completion	Positive	-2.4%	Completion of Vivasure Medical purchase with €100M upfront and earnouts.
Jan 07	Earnings date set	Neutral	+1.3%	Announcement of Feb 5, 2026 earnings release and investor conference call.
Jan 02	Investor conference	Neutral	-0.2%	Planned CEO presentation at 44th Annual J.P. Morgan Healthcare Conference.

Pattern Detected

Recent strategic and earnings-related announcements, including acquisitions and conference appearances, have often seen modest or negative next-day moves, indicating subdued reactions even to seemingly meaningful corporate updates.

Recent Company History

Over the last few months, Haemonetics has focused on portfolio reshaping and investor outreach. It completed the Vivasure Medical acquisition with contingent milestones and previously announced Attune Medical and OpSens deals. Earnings updates on Feb 5, 2026 and an earnings date notice in early January showed softer revenues but stronger profitability. The company also appeared at the 44th Annual J.P. Morgan Healthcare Conference. Today’s Raymond James conference participation continues this pattern of active engagement with the investment community.

Market Pulse Summary

This announcement highlights Haemonetics’ continued engagement with the investment community through...

Analysis

This announcement highlights Haemonetics’ continued engagement with the investment community through a fireside chat at a major institutional conference on March 2, 2026. It follows a series of earnings updates, portfolio acquisitions, and regulatory filings that detail improving profitability alongside softer revenues. Investors may focus on how management frames integration of recent deals, capital allocation priorities, and any qualitative commentary on demand trends during this event.

AI-generated analysis. Not financial advice.

BOSTON, Feb. 20, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 47th Annual Institutional Investors Conference on Monday, March 2, 2026 at 10:25 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.summitcast.com/view/VSr8zRPFYu9jT7Rm69ptdC/DrZt2UmuNYtnB5faJBzE4N.

A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-47th-annual-institutional-investors-conference-302693852.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) present at the Raymond James conference on March 2, 2026?

Haemonetics will present on March 2, 2026 at 10:25 a.m. ET. According to Haemonetics, Chris Simon, President and CEO, will participate in a fireside chat with investors at that scheduled time.

How can investors watch the Haemonetics (HAE) fireside chat webcast on March 2, 2026?

Investors can watch a live webcast on Haemonetics' Investor Relations website or the provided event link. According to Haemonetics, the webcast is publicly accessible for real-time viewing during the scheduled session.

Will Haemonetics (HAE) make a replay of the March 2, 2026 presentation available?

Yes. A replay will be accessible 12 hours after the event and will remain available for 90 days. According to Haemonetics, the recorded webcast replay will be posted on its Investor Relations website.

Who is representing Haemonetics (HAE) at the Raymond James 47th Annual Institutional Investors Conference?

Chris Simon, President and CEO of Haemonetics, will represent the company in the fireside chat. According to Haemonetics, he will discuss company developments with conference investors on March 2, 2026.

Where can investors find contact details for Haemonetics (HAE) investor relations ahead of the March 2, 2026 event?

Investor contacts are listed on Haemonetics' materials, including Vice President-Investor Relations Olga Guyette and Manager David Trenk. According to Haemonetics, contact phone numbers and emails are provided for investor inquiries.